5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with trypan blue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgstrom, P; Frost, G; Gjerset, RA; Haghighi, A; Huang, Y; Saadatmandi, N; Tyler, T | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and trypan blue
| Article | Year |
|---|---|
Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Topics: Adenoviridae; Animals; Annexin A5; bcl-2-Associated X Protein; Blotting, Western; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Primers; Exons; Female; Flow Cytometry; Galactosides; Genetic Vectors; Green Fluorescent Proteins; Humans; Indoles; Luciferases; Luminescent Proteins; Male; Mice; Mice, Nude; Neoplasms; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Trypan Blue; Tumor Cells, Cultured; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2002 |